At #OCTNewEngland, Alexandra Lyons will share real-world lessons from a complex oncology trial, including how stronger coordination helped accelerate start-up and kept enrollment moving. hubs.ly/Q04BlfPk0

Our team came together at Triangle Light The Night and Light The Night Connecticut to raise awareness and funds for blood cancer research. Thank you to everyone who joined us and who continue fighting for this important cause. #PremierResearch #LightTheNight

#SCRS26 is the perfect opportunity to spend time with the site community & exchange perspectives on what it takes to strengthen collaboration, support trial execution, & create a better experience for sites and patients. We are happy to be a part of it! hubs.ly/Q04BtDK30

Boston bound! Matt Garon and Bianca Fajardo will be representing Premier at the Veeva R&D and Quality Summit, joining life sciences colleagues for two days of ideas, insights, and conversations around the future of R&D. hubs.ly/Q04B997G0 #PremierResearch #VeevaSummit

What’s next for #CNS drug development? #CNSSummit2026 brings together industry leaders to explore emerging science and innovations shaping clinical research. We’re looking forward to being part of it! Meet with us: hubs.ly/Q04B93FF0 #PremierResearch

It's great to be together in Boston for #WHIS2026, where our team is spending time with the women’s health community and joining conversations around the challenges and opportunities shaping the field. hubs.ly/Q04Bgz5B0 #PremierResearch #WomensHealth

At #WODC, Jackie Brown, Adam Bloomfield, and more of our experts will be on-site to share perspectives and connect with teams advancing innovative therapies to patients. Drop by Booth #10.305 or schedule time with us here: hubs.ly/Q04B0bFq0

Immune checkpoint inhibitors can deliver remarkable, lasting responses, but there’s still room to optimize how they’re dosed. Our guide explores the potential to balance efficacy, safety, access, and cost: hubs.ly/Q04B6ZlN0 #PremierResearch #Oncology

Grade 2 or grade 3 AE? In early-phase #oncology trials, that distinction can influence dose escalation, phase transitions, and safety interpretation. Our new infographic explores why accurate AE grading matters. hubs.ly/Q04B01TS0 #PremierResearch #ClinicalTrials

The success of an oncology trial can hinge on decisions that extend beyond the treatment itself. Our #ESMO26 ePosters explore how eligibility criteria shape trial conduct & how medical oversight can support more efficient early-phase execution. hubs.ly/Q04zNzmy0

Who’s heading to OCT New England? We will be there to connect with biotech and pharma teams and share perspectives on clinical operations, study execution, and patient-focused trial delivery. You can get on their schedules ahead of time here: hubs.ly/Q04zYfvP0

Protocol-specific training, ongoing calibration, real-time feedback, and blinded data review can help sponsors reduce rater drift and maintain consistency throughout the trial. Read the blog for more: hubs.ly/Q04zKT__0

It's great to be on-site at #ACoP2026 with the pharmacometrics community. Our team is joining discussions around MIDD, quantitative clinical pharmacology, and the role of modeling in informing decisions across the development lifecycle. #PremierResearch #MIDD

Progress in rare disease requires bringing science, development strategy, and the patient perspective together. We’re looking forward to joining the rare disease community at the #NORDSummit later this month. Meet with us: hubs.ly/Q04zKLZh0 #PremierResearch #RareDisease

We’re heading to #SCRS2026 with a team whose experience spans clinical operations, patient centricity, site relationships, and complex therapeutic areas—bringing multiple perspectives to the conversations shaping site collaboration. Meet our experts: hubs.ly/Q04zKJmj0

We’re just days away from Blood Cancer United’s Triangle Light The Night, and our reason to walk hits close to home. This Saturday, we’ll gather in Cary, NC, with our CEO, John Ratliff, leading the way. Join us at the walk, register, or donate: hubs.ly/Q04zK_3s0